AU6924000A - Fluorenone compounds with modified 7-position substituents for treating and preventing brain and spinal injury - Google Patents
Fluorenone compounds with modified 7-position substituents for treating and preventing brain and spinal injuryInfo
- Publication number
- AU6924000A AU6924000A AU69240/00A AU6924000A AU6924000A AU 6924000 A AU6924000 A AU 6924000A AU 69240/00 A AU69240/00 A AU 69240/00A AU 6924000 A AU6924000 A AU 6924000A AU 6924000 A AU6924000 A AU 6924000A
- Authority
- AU
- Australia
- Prior art keywords
- treating
- modified
- spinal injury
- fluorenone compounds
- preventing brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
- C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37981699A | 1999-08-24 | 1999-08-24 | |
| US09379816 | 1999-08-24 | ||
| US09/379,656 US6251898B1 (en) | 1999-08-24 | 1999-08-24 | Medical use of fluorenone derivatives for treating and preventing brain and spinal injury |
| US09379656 | 1999-08-24 | ||
| PCT/US2000/022990 WO2001014334A1 (en) | 1999-08-24 | 2000-08-22 | Fluorenone compounds with modified 7-position substituents for treating and preventing brain and spinal injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6924000A true AU6924000A (en) | 2001-03-19 |
Family
ID=27008711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU69240/00A Abandoned AU6924000A (en) | 1999-08-24 | 2000-08-22 | Fluorenone compounds with modified 7-position substituents for treating and preventing brain and spinal injury |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6924000A (en) |
| WO (1) | WO2001014334A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008518959A (en) * | 2004-11-01 | 2008-06-05 | メルク エンド カムパニー インコーポレーテッド | Synthesis of 1,5-disubstituted-2-hydroxy-dibatetraen-6-one |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356313A (en) * | 1979-10-19 | 1982-10-26 | Merck & Co., Inc. | [(5,6,9a-substituted-3-oxo-1,2,9,9a-tetrahydro-3H-fluoren-7-yl)oxy]alkanoic and cycloalkanoic acid esters and their analogs, the parent acids and their salts |
| US4797391A (en) * | 1986-09-24 | 1989-01-10 | Merck & Co., Inc. | ((5,6-dichloro-3-oxo-9,9a-disubstituted-2,3,9,9a-tetrahydrofluoren-7-yl)oxy)alkanoic acids and alkanimidamides |
| US4731470A (en) * | 1986-11-03 | 1988-03-15 | Merck & Co., Inc. | [(5,6-dichloro-3-oxo-2,9a-alkano-2,3,9,9a-tetrahydro-1H-fluoren-7-yl)oxy]alkanoic acids and alkanimidamides |
| US4731471A (en) * | 1986-11-03 | 1988-03-15 | Merck & Co., Inc. | (5,6-dichloro-3-oxo-2,3,9,9a-tetrahydrofluoren-7-yl)-alkanoic acids and alkanimidamides bearing novel functional 9a-substituents |
-
2000
- 2000-08-22 WO PCT/US2000/022990 patent/WO2001014334A1/en active Application Filing
- 2000-08-22 AU AU69240/00A patent/AU6924000A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001014334A1 (en) | 2001-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AUPQ514600A0 (en) | Brain injury treatment | |
| AU2002211612A1 (en) | Methods for the treatment of a traumatic central nervous system injury | |
| AU6528800A (en) | Methods and apparatuses for radiation treatment | |
| IL139641A0 (en) | Quinazolines for treating brain tumor | |
| AU5056300A (en) | Devices and compounds for treating arterial restenosis | |
| IL136022A0 (en) | Apparatus for frameless stereotactic surgery | |
| IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
| HUP0105036A3 (en) | Imidazo-quinolin derivatives for treating sexual disturbances | |
| AU6910600A (en) | Methods for the treatment of mental disorders | |
| PL350679A1 (en) | Derivatives of 1-arenosulphonyl-2-arylpyrolydine and piperidine for treating central nervous system disorders | |
| AU2384500A (en) | Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders | |
| AU4363600A (en) | Treatment of and/or prophylaxis against brain and spinal cord injury | |
| AU5908300A (en) | Prevention and treatment of amyloid-associated disorders | |
| AU6062900A (en) | Substituted indole compounds and their use for the treatment of cancer | |
| HUP0200738A3 (en) | Method of the treatment of incontinence | |
| AUPQ232599A0 (en) | Drug for treating fractures | |
| AU2266801A (en) | Combination therapy for treating neurodegenerative disease | |
| EP1181308A4 (en) | Methods for the treatment of neuronal atrophy-associated dementia | |
| AU1225702A (en) | Methods and compounds for treating brain amyloidosis | |
| AU6924000A (en) | Fluorenone compounds with modified 7-position substituents for treating and preventing brain and spinal injury | |
| AU4480997A (en) | Screening methods for compounds useful in the treatment of schizophrenia | |
| CZ20011872A3 (en) | Isonipecotamides for the treatment of integrin-mediated disorders | |
| AU2566201A (en) | Compounds and methods for the treatment of pain | |
| AU4687501A (en) | Medicine for treating traumatic brain injury and other neuronal disorders | |
| AU1944297A (en) | Remedy for spinal injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |